28 October 2019 Comment
Those who develop prostate cancer at ages younger than 60 tend to exhibit a more aggressive and rapidly progressing form of the disease.
8 October 2019 Comment
The American Cancer Society estimates that 2,670 new cases of invasive breast cancer will be diagnosed in men in 2019, and 500 men will die from the disease.
25 September 2019 Comment
The incidence of prostate cancer varies worldwide, and the variation in rates may be attributed to prostate-specific antigen testing, a prostate cancer screening test.
24 September 2019 Comment
Pipeline agents may provide improved overall survival, but there is still no cure for metastatic castration-resistant prostate cancer (mCRPC).
6 August 2019 Analysis
This has been a landmark year for HIV treatment; a seven-year study confirmed that taking ART can prevent transmission between gay couples and a second patient has been effectively cured...
17 June 2019 Comment
Promising results for Astellas/Pfizer’s Xtandi and J&J’s Erleada were revealed at the annual American Society of Clinical Oncology (ASCO 2019) meeting in Chicago in early June.
9 May 2019 Comment
Only about 20% of patients who have the castration-resistant disease have nmCRPC, with the rest being metastatic.
5 April 2019 News
Gilead has submitted a supplemental new drug application (sNDA) to the US Food and Drug Administration (FDA) for antiviral Descovy (emtricitabine and tenofovir alafenamide) for pre-exposure prophylaxis (PrEP) to reduce...
2 April 2019 Comment
Scientists have detailed a mechanism by which Engrailed-2 (EN2) may provide a mode of communication between prostate cancer cells and the surrounding stroma.
28 March 2019 News
Clarus Therapeutics has announced that the US Food and Drug Administration (FDA) has approved its oral testosterone undecanoate (TU) Jatenzo for testosterone replacement therapy.